Shopping Cart 0
Cart Subtotal
USD 0

Quest PharmaTech Inc (QPT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Quest PharmaTech Inc (Quest), formerly Altachem Pharma Ltd is a pharmaceutical company that develops antibody based immunotherapeutic products for the treatment of cancer. The company develops products for treatment of cancer by combining immunotherapeutic antibodies with immunoglobulin G or E, chemotherapy, immune-adjuvants, or photodynamic therapy. It owns and utilizes photodynamic therapy technology for oncology and dermatology applications. It offers products such as anti CA125 MAb oregovomab, anti MUC1 MAb AR20.5 and SL052. Quest's anti CA125 MAb Oregovomab is an immunotherapeutic product for the treatment of ovarian cancer. The company's SL052 is an injectable formulation that is in phase I clinical trials used for the treatment of prostate cancer. Quest is headquartered in Edmonton, Alberta, Canada.

Quest PharmaTech Inc (QPT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Quest PharmaTech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Quest PharmaTech Inc, Medical Devices Deals, 2012 to YTD 2018 9

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

OncoQuest Acquires Immuno-Photodynamic Therapy Assets from Quest Pharma for USD2 Million 11

Quest PharmaTech To Acquire AllergoOncology Technology Of Advanced Immune Therapeutics 12

Venture Financing 13

OncoQuest Raises USD13 Million in Venture Financing 13

Partnerships 14

OncoQuest Enters into Agreement with Tesaro 14

OncoQuest and Shenzhen Hepalink Pharma Form Joint Venture 15

Quest PharmaTech Enters Into Co-Development Agreement With AD Biotech 16

Licensing Agreements 17

Quest PharmaTech Enters into Licensing Agreement with Bioceltran 17

Quest PharmaTech Enters Into Licensing Agreement With University Of California At Los Angeles For Cancer Treatment 18

Quest PharmaTech Enters Into Licensing Agreement With Oncovir For Hiltonol 19

Quest PharmaTech Enters Into Licensing Agreement With Stanford University For Anti-MUC1 IgE Technology 20

Equity Offering 21

OncoQuest Raises USD6 Million in Private Placement of Shares 21

Quest Pharma Raises USD1.34 Million in Private Placement of Shares upon Exercise of Warrants 22

OncoQuest Raises USD13 Million in Private Placement of Preference Shares 23

Quest PharmaTech Raises USD1.5 Million in Private Placement of Shares 24

Quest PharmaTech Raises USD0.8 Million in Private Placement of Units 25

Quest PharmaTech Completes Private Placement Of Units For USD 1 Million 26

Quest PharmaTech Announces Private Placement Of Shares For USD 7.7 Million 27

Quest PharmaTech Completes Private Placement Of Shares For USD 0.5 Million 28

Asset Transactions 29

OncoQuest Acquires Immuno-Photodynamic Therapy Assets from Quest Pharma for USD2 Million 29

Acquisition 30

Quest PharmaTech to Acquire 32% Stake in Natural Rf Life Sciences for USD0.4 Million 30

Quest PharmaTech Inc-Key Competitors 31

Quest PharmaTech Inc-Key Employees 32

Quest PharmaTech Inc-Locations And Subsidiaries 33

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 34

Corporate Communications 34

Jul 19, 2017: Quest PharmaTech Appoints Mr. Mark Lievonen, former President of Sanofi Pasteur Limited, to the Board of Directors 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35


List Of Figure

List of Figures

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Quest PharmaTech Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Quest PharmaTech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Quest PharmaTech Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Quest PharmaTech Inc, Medical Devices Deals, 2012 to YTD 2018 9

Quest PharmaTech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

OncoQuest Acquires Immuno-Photodynamic Therapy Assets from Quest Pharma for USD2 Million 11

Quest PharmaTech To Acquire AllergoOncology Technology Of Advanced Immune Therapeutics 12

OncoQuest Raises USD13 Million in Venture Financing 13

OncoQuest Enters into Agreement with Tesaro 14

OncoQuest and Shenzhen Hepalink Pharma Form Joint Venture 15

Quest PharmaTech Enters Into Co-Development Agreement With AD Biotech 16

Quest PharmaTech Enters into Licensing Agreement with Bioceltran 17

Quest PharmaTech Enters Into Licensing Agreement With University Of California At Los Angeles For Cancer Treatment 18

Quest PharmaTech Enters Into Licensing Agreement With Oncovir For Hiltonol 19

Quest PharmaTech Enters Into Licensing Agreement With Stanford University For Anti-MUC1 IgE Technology 20

OncoQuest Raises USD6 Million in Private Placement of Shares 21

Quest Pharma Raises USD1.34 Million in Private Placement of Shares upon Exercise of Warrants 22

OncoQuest Raises USD13 Million in Private Placement of Preference Shares 23

Quest PharmaTech Raises USD1.5 Million in Private Placement of Shares 24

Quest PharmaTech Raises USD0.8 Million in Private Placement of Units 25

Quest PharmaTech Completes Private Placement Of Units For USD 1 Million 26

Quest PharmaTech Announces Private Placement Of Shares For USD 7.7 Million 27

Quest PharmaTech Completes Private Placement Of Shares For USD 0.5 Million 28

OncoQuest Acquires Immuno-Photodynamic Therapy Assets from Quest Pharma for USD2 Million 29

Quest PharmaTech to Acquire 32% Stake in Natural Rf Life Sciences for USD0.4 Million 30

Quest PharmaTech Inc, Key Competitors 31

Quest PharmaTech Inc, Key Employees 32

Quest PharmaTech Inc, Subsidiaries 33

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Quest PharmaTech Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.